Group 1 - The core point of the article is that Sely Medical (SH 603716) held a temporary board meeting on November 11, 2025, to discuss the proposal for providing guarantee limits for its subsidiary [1] - For the fiscal year 2024, Sely Medical's revenue composition is 97.09% from commercial activities and 2.91% from industrial activities [1] - As of the report date, Sely Medical has a market capitalization of 4.9 billion yuan [1] Group 2 - Prior to the arrest of Peking University Pharmaceutical's chairman Xu Xiren, police had investigated the group's factory premises, indicating potential issues within the company [1] - Internal sources suggest that the group's assets have been disposed of by Xu, with significant amounts of funds unaccounted for [1]

Group 1 - The core viewpoint of the article highlights that Yangpu Medical (SZ 300030) held its 14th meeting of the 6th board of directors on August 13, 2025, to review the "2025 Semi-Annual Report" and other documents [1] - For the year 2024, Yangpu Medical's revenue composition shows that industrial revenue accounts for 99.18%, while financing leasing contributes 0.82% [1] - As of the report, Yangpu Medical has a market capitalization of 2.6 billion yuan [1]